Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry
Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is…